ORMP SEC Filings: 8-K, 10-Q, S-3 & 424B

Financials

TYPE

HEADLINE

FILED AT

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Aug 10, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

May 19, 2026

NT 10-Q

Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB

May 15, 2026

10-K

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Mar 26, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Nov 13, 2025

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Aug 14, 2025

News

TYPE

HEADLINE

FILED AT

8-K

Oramed Pharmaceuticals Inc. Reports Voting Results from 2026 Annual Meeting of Stockholders

Sep 17, 2026

8-K

Oramed Pharmaceuticals Amends Bylaws and Extends Payment Obligations with Scilex Holding Company

Jun 30, 2026

8-K

Oramed Pharmaceuticals Completes Disposition of Oratech to Lifeward and Investment in Lifeward Notes

Mar 31, 2026

8-K

Oramed Pharmaceuticals Enters Warrant Agreement with Scilex, Deferring Payment for New Warrants

Feb 20, 2026

8-K

Oramed Transfers POD™ Technology to Lifeward in Strategic Deal

Jan 14, 2026

8-K

Oramed Secures $18 Million Payment from Scilex; Board Approves Dividend

Jan 7, 2026

Prospectus

TYPE

HEADLINE

FILED AT

424B5

ATM | Offering amount: $75,000,000 | Amount sold to date: $26,990,000

Mar 18, 2024

424B5

SHELF OFFERING | Shares amount: 2,000,000 | Share price: $25.00 | Offering amount: $50,000,000.00

Nov 4, 2021

424B5

ATM | Offering amount: $100,000,000

Sep 1, 2021

424B7

SHARE RESALE REGISTRATION | Shares amount: 3,007,680 | Warrants amount: 547,771

Aug 13, 2021

424B5

ATM | Offering amount: $28,000,000 | Amount sold to date: $38,548,161

Jun 16, 2021

424B5

Shares having an aggregate offering price of up to $40,000,000.-

Dec 1, 2020

Registrations

TYPE

HEADLINE

FILED AT

8-A12B

Form 8-A12B - Registration of securities [Section 12(b)]

Nov 17, 2025

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

Aug 21, 2025

S-8

Registration

Jul 12, 2022

S-3

SHELF | ATM | Offering amount: $250,000,000.00 EFFECTIVE

Jul 15, 2021

S-3MEF

Registration-

Jun 16, 2021

S-3

Up to 3,007,680 Shares of Common Stock- EFFECTIVE

Feb 3, 2021

Proxies

TYPE

HEADLINE

FILED AT

DEFA14A

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Aug 3, 2026

DEF 14A